Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Metabolic Effects of Methionine in Schizophrenic Patients pretreated with a Monoamine Oxidase Inhibitor

Abstract

ORAL administration of a large amount of methionine to schizophrenic patients who had been treated with a monoamine oxidase inhibitor (MAOI) was reported to produce psychic symptoms which have been interpreted either as an intensification of schizophrenic symptoms or as superimposed toxic symptoms1–4. The effects of methionine and MAOI have been explained as an increase in the amounts of methylated amines, such as bufotenin, N,N-dimethyltryptamine, 3,4-dimethoxyphenylethylamine or unknown amines which have been claimed to be psychotogenic substances. One of the purposes of the present experiments is to determine whether methionine increases the rates of N or O-methylation of catechol and indolic amines.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Pollin, W., Cardon, P. V., and Kety, S. S., Science, 133, 104 (1961).

    Article  ADS  CAS  Google Scholar 

  2. Brune, G. G., and Himwich, H. E., J. Nerv. Ment. Dis., 134, 447 (1962).

    Article  CAS  Google Scholar 

  3. Park, L. C., Baldessarini, R. J., and Kety, S. S., Arch. Gen. Psychiat., 12, 346 (1965).

    Article  CAS  Google Scholar 

  4. Berlet, H. H., Matsumoto, K., Pscheidt, G. R., Spaide, J., Bull, C., and Himwich, H. E., Arch. Gen. Psychiat., 13, 521 (1965).

    Article  CAS  Google Scholar 

  5. Kakimoto, Y., and Armstrong, M. D., J. Biol. Chem., 237, 208 (1962).

    CAS  PubMed  Google Scholar 

  6. Friedhoff, A. J., and Van Winkle, E., Nature, 194, 897 (1962).

    Article  ADS  CAS  Google Scholar 

  7. Takesada, M., Kakimoto, Y., Sano, I., and Kaneko, Z., Nature, 199, 203 (1963).

    Article  ADS  CAS  Google Scholar 

  8. Von Euler, U. S., and Floding, I., J. Clin. Lab. Invest., 8, 288 (1956).

    Article  Google Scholar 

  9. Taniguchi, K., Kakimoto, Y., and Armstrong, M. D., J. Lab. Clin. Med., 64, 469 (1964).

    CAS  PubMed  Google Scholar 

  10. Lavine, T. F., J. Biol. Chem., 169, 477 (1947).

    CAS  PubMed  Google Scholar 

  11. Walshe, J. M., Quart. J. Med., 22, 483 (1953).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

KAKIMOTO, Y., SANO, I., KANAZAWA, A. et al. Metabolic Effects of Methionine in Schizophrenic Patients pretreated with a Monoamine Oxidase Inhibitor. Nature 216, 1110–1111 (1967). https://doi.org/10.1038/2161110a0

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/2161110a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing